| |
|
Form Serial Number: |
DA20220308E00331
|
| 1.
Date of relevant event: |
23/02/2022
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02157 |
| 4.
Name of listed corporation: |
Lepu Biopharma Co., Ltd. - B - H shares |
| 5.
Class of shares: |
H Shares |
| 6.
Number of issued shares in class: |
1,604,277,474 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
Pu |
| (Other names) |
Zhongjie |
|
|
|
| 10.
Name of director (Chinese): |
蒲忠傑 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1701 | Miscellaneous
On listing of the corporation or a class of shares of the listed corporation |
|
|
| 2201 | Interest of corporation controlled by you |
|
658,591,549 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| | | |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 658,591,549 | 41.05 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| Lepu Medical Technology (Beijing) Co., Ltd. (樂普(北京)醫療器械股份有限公司) | 中国北京市昌平區超前路37號 | 蒲忠傑 | 25.25 | Y | |
| Beijing Houde Yimin Investment Management Co., Ltd. (北京厚德義民投資管理有限公司) | 中国北京市大興區黃村東大街38號院3號樓12層1212室 | 蒲忠傑 | 100.00 | N | |
| Ningbo Houde Yimin Information Technology Co., Ltd. (寧波厚德義民信息科技有限公司) | 中国浙江省寧波市北崙區梅山大道商務中心三號辦公樓966室 | Beijing Houde Yimin Investment Management Co., Ltd. (北京厚德義民投資管理有限公司) | 100.00 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
蒲忠傑 is the Actual Controller of Lepu Medical Technology (Beijing) Co., Ltd. (樂普(北京)醫療器械股份有限公司). According to Article 13.1(6) of Shenzhen Stock Exchange Gem Stock Listing Rules (Amended in December 2020), “Actual Controller” refers to the person who can actually control the bhavior of the company through investment relationship, agreement or other arrangements.
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
08/03/2022
(dd/mm/yyyy)
|
| |